SA

Shubhangi Ashok Gupte

Active Director Director DIN 10438313
DIN 10438313 First appointment Dec 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Shubhangi Ashok Gupte

Data last updated:

Shubhangi Ashok Gupte is a Director at Ekviraneuro Healthinstitute Private Limited (since 2023). Ekviraneuro Healthinstitute Private Limited reported revenue of ₹51,522 (FY 2025).

DIN 10438313
Primary Designation Director
First Appointment 26 Dec 2023
Oldest Company Age 2 yrs
Largest company Ekviraneuro Healthinstitute Private Limited · ₹51,522 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Dec 20232023₹51,522 (FY 2025)Active

Board colleagues of Shubhangi Ashok Gupte

Directorship timeline

Open interactive timeline →
Ekviraneuro Healthinstitute Private Limited
Premium access

Shareholding and investment profile for Shubhangi Ashok Gupte

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubhangi Ashok Gupte

Shubhangi Ashok Gupte currently holds 1 directorship: Ekviraneuro Healthinstitute Private Limited (Director, since 26 Dec 2023, revenue ₹51,522 (FY 2025)).

Shubhangi Ashok Gupte was first appointed on 26 Dec 2023 as Director at Ekviraneuro Healthinstitute Private Limited.

The current boards of Shubhangi Ashok Gupte's companies include Akshay Ashok Gupte (Ekviraneuro Healthinstitute Private Limited), Ashok Gupte Kamalakar (Ekviraneuro Healthinstitute Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available